MedTech Acquisition - Warrants (18/12/2025) EBIT

The latest EBIT for MTACW is $-29M as of June 2026. That compares with $-32M in the prior-year period — up 10.7% year over year. That is below the sector sector average of $-6.4M. Investors often review this figure alongside MedTech Acquisition - Warrants (18/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MTACW's EBIT moved from $-32M to $-29M — a 10.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedTech Acquisition - Warrants (18/12/2025)'s operating scale or balance-sheet position.

Against its sector companies, MTACW currently prints $-29M for EBIT, while the sector average sits near $-6.4M. That is roughly 346.0% below the sector mean. Large gaps often invite a closer look at MedTech Acquisition - Warrants (18/12/2025)'s growth, margins, and balance sheet.

A EBIT figure of $-29M for MTACW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.

After noting MTACW's EBIT ($-29M), review year-over-year change from $-32M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.